# Shopify timeline entity: /record/shopify.md id: ent_shopify ## undated - undated | ticker | SHOP | valid | [clm_5D28BC28AC66](/claim/clm_5D28BC28AC66.md) - undated | cik | 0001594805 | valid | [clm_82018CA73260](/claim/clm_82018CA73260.md) - undated | registrant_name | SHOPIFY INC. | valid | [clm_91D29BEDC81D](/claim/clm_91D29BEDC81D.md) - undated | listed_on | Nasdaq | valid | [clm_C78D6C101FAB](/claim/clm_C78D6C101FAB.md) - undated | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_F206F455F216](/claim/clm_F206F455F216.md) - undated | fiscal_year_end | 12-31 | valid | [clm_FB15E8CDEDFE](/claim/clm_FB15E8CDEDFE.md) - undated | state_of_incorporation | Z4 | valid | [clm_FE5797312E4D](/claim/clm_FE5797312E4D.md) - undated | website | https://pt.shopify.com | unverified | [clm_1AEBA91C8720](/claim/clm_1AEBA91C8720.md) - undated | website | https://www.shopify.com/jp | unverified | [clm_26113A002657](/claim/clm_26113A002657.md) - undated | website | https://es.shopify.com/ | unverified | [clm_35A700EB389C](/claim/clm_35A700EB389C.md) - undated | country | Canada | unverified | [clm_48414399C5A3](/claim/clm_48414399C5A3.md) - undated | legal_form | corporation | unverified | [clm_5D850BE35471](/claim/clm_5D850BE35471.md) - undated | industry | e-commerce | unverified | [clm_67C3993945BC](/claim/clm_67C3993945BC.md) - undated | website | http://www.shopify.com | unverified | [clm_8DA29AB17655](/claim/clm_8DA29AB17655.md) - undated | website | https://www.shopify.com/fr | unverified | [clm_AE4111AE4455](/claim/clm_AE4111AE4455.md) - undated | website | https://www.shopify.com | unverified | [clm_BBE302440BBA](/claim/clm_BBE302440BBA.md) - undated | website | https://en.shopify.nl/ | unverified | [clm_E54FCCFE0A5B](/claim/clm_E54FCCFE0A5B.md) - undated | headquarters | Ottawa | unverified | [clm_EC4A10EE4E38](/claim/clm_EC4A10EE4E38.md) - undated | subsidiary | Oberlo | unverified | [clm_ED0CCF3D37FF](/claim/clm_ED0CCF3D37FF.md) ## 2008 - 2008-11-03 | x_username | Shopify | unverified | [clm_C66DCC6F588D](/claim/clm_C66DCC6F588D.md) ## 2012 - 2012-12-31 to 2013-12-31 | total_equity | 17,969,000 United States dollar | superseded | [clm_3CD0431259C4](/claim/clm_3CD0431259C4.md) - 2012-12-31 to 2013-12-31 | cash_and_equivalents | 17,655,000 United States dollar | superseded | [clm_5A608B0A2251](/claim/clm_5A608B0A2251.md) ## 2013 - 2013-12-31 to 2014-12-31 | total_equity | 85,381,000 United States dollar | superseded | [clm_079BCD877592](/claim/clm_079BCD877592.md) - 2013-12-31 to 2014-12-31 | cash_and_equivalents | 83,529,000 United States dollar | superseded | [clm_B525B708157A](/claim/clm_B525B708157A.md) - 2013-12-31 to 2014-12-31 | research_and_development | 13,682,000 United States dollar | superseded | [clm_D647756EF9F7](/claim/clm_D647756EF9F7.md) - 2013-12-31 to 2014-12-31 | operating_income | -4,269,000 United States dollar | superseded | [clm_D70CB0C46168](/claim/clm_D70CB0C46168.md) - 2013-12-31 to 2014-12-31 | net_income | -4,837,000 United States dollar | superseded | [clm_F528451EAFC7](/claim/clm_F528451EAFC7.md) ## 2014 - 2014-12-31 to 2015-12-31 | net_income | -22,311,000 United States dollar | superseded | [clm_168C1B166057](/claim/clm_168C1B166057.md) - 2014-12-31 to 2015-12-31 | total_equity | 67,732,000 United States dollar | superseded | [clm_27052C3F8977](/claim/clm_27052C3F8977.md) - 2014-12-31 to 2015-12-31 | research_and_development | 25,915,000 United States dollar | superseded | [clm_36CE87E3640E](/claim/clm_36CE87E3640E.md) - 2014-12-31 to 2015-12-31 | total_assets | 95,193,000 United States dollar | superseded | [clm_3F0585139454](/claim/clm_3F0585139454.md) - 2014-12-31 to 2015-12-31 | cash_and_equivalents | 41,953,000 United States dollar | superseded | [clm_65D1DBED9686](/claim/clm_65D1DBED9686.md) - 2014-12-31 to 2015-12-31 | operating_income | -21,615,000 United States dollar | superseded | [clm_95F8B5D5E2EE](/claim/clm_95F8B5D5E2EE.md) ## 2015 - 2015-12-31 to 2016-12-31 | total_assets | 243,712,000 United States dollar | superseded | [clm_11A03A63AF82](/claim/clm_11A03A63AF82.md) - 2015-12-31 to 2016-12-31 | research_and_development | 39,722,000 United States dollar | superseded | [clm_1877DBAFFC7A](/claim/clm_1877DBAFFC7A.md) - 2015-12-31 to 2016-12-31 | total_equity | 195,317,000 United States dollar | superseded | [clm_1E387E77A294](/claim/clm_1E387E77A294.md) - 2015-12-31 to 2016-12-31 | net_income | -18,790,000 United States dollar | superseded | [clm_57B0D04A1AF8](/claim/clm_57B0D04A1AF8.md) - 2015-12-31 to 2016-12-31 | cash_and_equivalents | 110,070,000 United States dollar | superseded | [clm_66293F155816](/claim/clm_66293F155816.md) - 2015-12-31 to 2016-12-31 | operating_income | -17,756,000 United States dollar | superseded | [clm_A34094A6B224](/claim/clm_A34094A6B224.md) ## 2016 - 2016-12-31 to 2017-12-31 | net_income | -35,355,000 United States dollar | superseded | [clm_057D2100025C](/claim/clm_057D2100025C.md) - 2016-12-31 to 2017-12-31 | cash_and_equivalents | 84,013,000 United States dollar | superseded | [clm_880A3C1B83DF](/claim/clm_880A3C1B83DF.md) - 2016-12-31 to 2017-12-31 | operating_income | -37,165,000 United States dollar | superseded | [clm_9149D0521A61](/claim/clm_9149D0521A61.md) - 2016-12-31 to 2017-12-31 | research_and_development | 74,336,000 United States dollar | superseded | [clm_C513E141A22F](/claim/clm_C513E141A22F.md) - 2016-12-31 to 2017-12-31 | total_assets | 490,558,000 United States dollar | superseded | [clm_CA4F075023E8](/claim/clm_CA4F075023E8.md) - 2016-12-31 to 2017-12-31 | total_equity | 410,476,000 United States dollar | superseded | [clm_DAB0FAB94540](/claim/clm_DAB0FAB94540.md) ## 2017 - 2017-12-31 to 2018-12-31 | revenue | 673,304,000 United States dollar | superseded | [clm_12ACCF6D8C1E](/claim/clm_12ACCF6D8C1E.md) - 2017-12-31 to 2018-12-31 | net_income | -39,995,000 United States dollar | superseded | [clm_1998BD0E9D63](/claim/clm_1998BD0E9D63.md) - 2017-12-31 to 2018-12-31 | research_and_development | 135,997,000 United States dollar | superseded | [clm_20EA17174BC5](/claim/clm_20EA17174BC5.md) - 2017-12-31 to 2018-12-31 | cash_and_equivalents | 141,677,000 United States dollar | superseded | [clm_9D9A970B99B6](/claim/clm_9D9A970B99B6.md) - 2017-12-31 to 2018-12-31 | operating_income | -49,157,000 United States dollar | superseded | [clm_B7B88C408724](/claim/clm_B7B88C408724.md) - 2017-12-31 to 2018-12-31 | total_assets | 1,113,564,000 United States dollar | superseded | [clm_E0890588E066](/claim/clm_E0890588E066.md) - 2017-12-31 to 2018-12-31 | total_equity | 1,001,100,000 United States dollar | superseded | [clm_F3787FE0A50E](/claim/clm_F3787FE0A50E.md) ## 2018 - 2018-12-31 to 2019-12-31 | total_equity | 2,090,768,000 United States dollar | superseded | [clm_2E9D96C92AA1](/claim/clm_2E9D96C92AA1.md) - 2018-12-31 to 2019-12-31 | cash_and_equivalents | 410,683,000 United States dollar | superseded | [clm_66400BE1D764](/claim/clm_66400BE1D764.md) - 2018-12-31 to 2019-12-31 | total_assets | 2,254,785,000 United States dollar | superseded | [clm_8FC073C47577](/claim/clm_8FC073C47577.md) - 2018-12-31 to 2019-12-31 | net_income | -64,553,000 United States dollar | superseded | [clm_A0D32B64A294](/claim/clm_A0D32B64A294.md) - 2018-12-31 to 2019-12-31 | research_and_development | 230,674,000 United States dollar | superseded | [clm_A2243B7F7B21](/claim/clm_A2243B7F7B21.md) - 2018-12-31 to 2019-12-31 | operating_income | -91,920,000 United States dollar | superseded | [clm_C8C3033FE957](/claim/clm_C8C3033FE957.md) - 2018-12-31 to 2019-12-31 | revenue | 1,073,229,000 United States dollar | superseded | [clm_E1D15B973E4F](/claim/clm_E1D15B973E4F.md) ## 2019 - 2019-12-31 to 2020-12-31 | total_assets | 3,489,479,000 United States dollar | superseded | [clm_011A6FF71F4F](/claim/clm_011A6FF71F4F.md) - 2019-12-31 to 2020-12-31 | revenue | 1,578,173,000 United States dollar | superseded | [clm_58F9E7CCA9BE](/claim/clm_58F9E7CCA9BE.md) - 2019-12-31 to 2020-12-31 | net_income | -124,842,000 United States dollar | superseded | [clm_6E19D29056F0](/claim/clm_6E19D29056F0.md) - 2019-12-31 to 2020-12-31 | research_and_development | 355,015,000 United States dollar | superseded | [clm_947FA62508A5](/claim/clm_947FA62508A5.md) - 2019-12-31 to 2020-12-31 | operating_income | -141,147,000 United States dollar | superseded | [clm_99B219289792](/claim/clm_99B219289792.md) - 2019-12-31 to 2020-12-31 | cash_and_equivalents | 649,916,000 United States dollar | superseded | [clm_BF138DB21DF6](/claim/clm_BF138DB21DF6.md) - 2019-12-31 to 2020-12-31 | total_equity | 3,015,734,000 United States dollar | superseded | [clm_EF8528C13A90](/claim/clm_EF8528C13A90.md) ## 2020 - 2020-12-31 to 2021-12-31 | total_assets | 7,762,905,000 United States dollar | superseded | [clm_041FD369349A](/claim/clm_041FD369349A.md) - 2020-12-31 to 2021-12-31 | net_income | 319,509,000 United States dollar | superseded | [clm_18FE944F32AE](/claim/clm_18FE944F32AE.md) - 2020-12-31 to 2021-12-31 | cash_and_equivalents | 2,703,597,000 United States dollar | superseded | [clm_2FE507D5CB33](/claim/clm_2FE507D5CB33.md) - 2020-12-31 to 2021-12-31 | revenue | 2,929,491,000 United States dollar | superseded | [clm_8C6C64FCD156](/claim/clm_8C6C64FCD156.md) - 2020-12-31 to 2021-12-31 | total_equity | 6,400,723,000 United States dollar | superseded | [clm_A35B6A1E13C8](/claim/clm_A35B6A1E13C8.md) - 2020-12-31 to 2021-12-31 | research_and_development | 552,127,000 United States dollar | superseded | [clm_BE701527A93C](/claim/clm_BE701527A93C.md) - 2020-12-31 to 2021-12-31 | operating_income | 90,153,000 United States dollar | superseded | [clm_EC814E022FBA](/claim/clm_EC814E022FBA.md) ## 2021 - 2021-12-31 to 2022-12-31 | cash_and_equivalents | 2,502,992,000 United States dollar | superseded | [clm_0C74B1791D2B](/claim/clm_0C74B1791D2B.md) - 2021-12-31 to 2023-12-31 | employees | 10,000 | superseded | [clm_254BF4F4D7EC](/claim/clm_254BF4F4D7EC.md) - 2021-12-31 to 2022-12-31 | total_equity | 11,133,341,000 United States dollar | superseded | [clm_272FCBDEFDCA](/claim/clm_272FCBDEFDCA.md) - 2021-12-31 to 2022-12-31 | revenue | 4,611,856,000 United States dollar | superseded | [clm_977106B5396F](/claim/clm_977106B5396F.md) - 2021-12-31 to 2022-12-31 | total_assets | 13,340,172,000 United States dollar | superseded | [clm_98CB2C55F315](/claim/clm_98CB2C55F315.md) - 2021-12-31 to 2022-12-31 | net_income | 2,914,659,000 United States dollar | superseded | [clm_BD362A80DC32](/claim/clm_BD362A80DC32.md) - 2021-12-31 to 2022-12-31 | research_and_development | 854,383,000 United States dollar | superseded | [clm_D58D9F7737C5](/claim/clm_D58D9F7737C5.md) - 2021-12-31 to 2022-12-31 | operating_income | 268,643,000 United States dollar | superseded | [clm_E3E570384651](/claim/clm_E3E570384651.md) - 2021-12-31 to 2022-12-31 | revenue | 3,231,000,000 United States dollar | superseded | [clm_E6C2A56600D6](/claim/clm_E6C2A56600D6.md) ## 2022 - 2022-01-05 to 2022-01-05 | market_cap | 47,750,000,000 United States dollar | superseded | [clm_301AAE2986EE](/claim/clm_301AAE2986EE.md) - 2022-12-31 to 2023-12-31 | total_assets | 10,757,151,000 United States dollar | superseded | [clm_2A471ACD7F29](/claim/clm_2A471ACD7F29.md) - 2022-12-31 to 2023-12-31 | revenue | 5,600,000,000 United States dollar | superseded | [clm_441E25C73F4E](/claim/clm_441E25C73F4E.md) - 2022-12-31 to 2023-12-31 | operating_income | -822,299,000 United States dollar | superseded | [clm_78938B2BE49A](/claim/clm_78938B2BE49A.md) - 2022-12-31 to 2023-12-31 | net_income | -3,460,418,000 United States dollar | superseded | [clm_B952729DA421](/claim/clm_B952729DA421.md) - 2022-12-31 to 2023-12-31 | total_equity | 8,238,889,000 United States dollar | superseded | [clm_C710EF64C6A3](/claim/clm_C710EF64C6A3.md) - 2022-12-31 to 2023-12-31 | research_and_development | 1,503,234,000 United States dollar | superseded | [clm_D867B69FB544](/claim/clm_D867B69FB544.md) - 2022-12-31 to 2023-12-31 | cash_and_equivalents | 1,649,328,000 United States dollar | superseded | [clm_F81B1ADB1F1C](/claim/clm_F81B1ADB1F1C.md) ## 2023 - 2023-12-31 to 2025-12-31 | employees | 8,300 | superseded | [clm_1EDFCF50591D](/claim/clm_1EDFCF50591D.md) - 2023-12-31 to 2024-12-31 | revenue | 7,060,000,000 United States dollar | superseded | [clm_205EF112421C](/claim/clm_205EF112421C.md) - 2023-12-31 to 2024-12-31 | net_income | 132,000,000 United States dollar | superseded | [clm_7389E99FC0E2](/claim/clm_7389E99FC0E2.md) - 2023-12-31 to 2024-12-31 | research_and_development | 1,730,000,000 United States dollar | superseded | [clm_81BB918AF9F5](/claim/clm_81BB918AF9F5.md) - 2023-12-31 to 2024-12-31 | total_assets | 11,299,000,000 United States dollar | superseded | [clm_AE0830671B63](/claim/clm_AE0830671B63.md) - 2023-12-31 to 2024-12-31 | cash_and_equivalents | 1,413,000,000 United States dollar | superseded | [clm_B37744D2FF41](/claim/clm_B37744D2FF41.md) - 2023-12-31 to 2024-03-31 | total_equity | 9,066,000,000 United States dollar | superseded | [clm_BA95419E94CA](/claim/clm_BA95419E94CA.md) - 2023-12-31 to 2024-12-31 | operating_income | -1,418,000,000 United States dollar | superseded | [clm_E0561566C229](/claim/clm_E0561566C229.md) ## 2024 - 2024-03-31 to 2024-06-30 | quarterly_operating_income | 86,000,000 United States dollar | superseded | [clm_19432F09E5E0](/claim/clm_19432F09E5E0.md) - 2024-03-31 to 2024-06-30 | quarterly_net_income | -273,000,000 United States dollar | superseded | [clm_28F05F1632BE](/claim/clm_28F05F1632BE.md) - 2024-03-31 to 2024-06-30 | quarterly_revenue | 1,861,000,000 United States dollar | superseded | [clm_9E11154E7AD0](/claim/clm_9E11154E7AD0.md) - 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 335,000,000 United States dollar | superseded | [clm_AC38F1CFBCC8](/claim/clm_AC38F1CFBCC8.md) - 2024-03-31 to 2024-06-30 | total_equity | 8,893,000,000 United States dollar | superseded | [clm_CAA7F70B5422](/claim/clm_CAA7F70B5422.md) - 2024-06-30 to 2024-09-30 | total_equity | 9,172,000,000 United States dollar | superseded | [clm_060F1885C357](/claim/clm_060F1885C357.md) - 2024-06-30 to 2024-09-30 | quarterly_net_income | 171,000,000 United States dollar | superseded | [clm_49765AA80088](/claim/clm_49765AA80088.md) - 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 349,000,000 United States dollar | superseded | [clm_785752327DA6](/claim/clm_785752327DA6.md) - 2024-06-30 to 2024-09-30 | quarterly_revenue | 2,045,000,000 United States dollar | superseded | [clm_8D63775BEEA2](/claim/clm_8D63775BEEA2.md) - 2024-06-30 to 2024-09-30 | quarterly_operating_income | 241,000,000 United States dollar | superseded | [clm_BB29D4CF4A59](/claim/clm_BB29D4CF4A59.md) - 2024-09-30 to 2025-03-31 | quarterly_operating_income | 283,000,000 United States dollar | superseded | [clm_9078357A931F](/claim/clm_9078357A931F.md) - 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 332,000,000 United States dollar | superseded | [clm_9D55E1C63368](/claim/clm_9D55E1C63368.md) - 2024-09-30 to 2025-03-31 | quarterly_revenue | 2,162,000,000 United States dollar | superseded | [clm_AE14F04EBD8C](/claim/clm_AE14F04EBD8C.md) - 2024-09-30 to 2025-03-31 | quarterly_net_income | 828,000,000 United States dollar | superseded | [clm_C29B989D0EA4](/claim/clm_C29B989D0EA4.md) - 2024-09-30 to 2024-12-31 | total_equity | 10,118,000,000 United States dollar | superseded | [clm_EF17D031A48D](/claim/clm_EF17D031A48D.md) - 2024-12-31 to 2025-03-31 | total_equity | 11,558,000,000 United States dollar | superseded | [clm_605BC5452331](/claim/clm_605BC5452331.md) - 2024-12-31 to 2025-12-31 | revenue | 8,880,000,000 United States dollar | superseded | [clm_855F7BB6904F](/claim/clm_855F7BB6904F.md) - 2024-12-31 to 2025-03-31 | cash_and_equivalents | 1,498,000,000 United States dollar | superseded | [clm_A9D2D9CE54C0](/claim/clm_A9D2D9CE54C0.md) - 2024-12-31 to 2025-12-31 | net_income | 2,019,000,000 United States dollar | superseded | [clm_C02192C17CB3](/claim/clm_C02192C17CB3.md) - 2024-12-31 to 2025-12-31 | operating_income | 1,075,000,000 United States dollar | superseded | [clm_E245C5D95BEC](/claim/clm_E245C5D95BEC.md) - 2024-12-31 to 2025-03-31 | total_assets | 13,924,000,000 United States dollar | superseded | [clm_F396D79F56D6](/claim/clm_F396D79F56D6.md) - 2024-12-31 to 2025-12-31 | research_and_development | 1,367,000,000 United States dollar | superseded | [clm_FF7B55ABDE37](/claim/clm_FF7B55ABDE37.md) ## 2025 - 2025-03-18 | delisting_notice | New York Stock Exchange | valid | [clm_89F0BC8F877F](/claim/clm_89F0BC8F877F.md) - 2025-03-31 to 2025-06-30 | quarterly_revenue | 2,360,000,000 United States dollar | superseded | [clm_45930992BC79](/claim/clm_45930992BC79.md) - 2025-03-31 to 2025-06-30 | quarterly_operating_income | 203,000,000 United States dollar | superseded | [clm_52643F3412F7](/claim/clm_52643F3412F7.md) - 2025-03-31 to 2025-06-30 | total_assets | 13,400,000,000 United States dollar | superseded | [clm_68932C3CF874](/claim/clm_68932C3CF874.md) - 2025-03-31 to 2025-06-30 | quarterly_net_income | -682,000,000 United States dollar | superseded | [clm_809CA00801E0](/claim/clm_809CA00801E0.md) - 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 377,000,000 United States dollar | superseded | [clm_A575EE1A045A](/claim/clm_A575EE1A045A.md) - 2025-03-31 to 2025-06-30 | total_equity | 11,051,000,000 United States dollar | superseded | [clm_B2433E86289B](/claim/clm_B2433E86289B.md) - 2025-03-31 to 2025-06-30 | cash_and_equivalents | 1,309,000,000 United States dollar | superseded | [clm_D8D05A2B28BA](/claim/clm_D8D05A2B28BA.md) - 2025-06-30 to 2025-09-30 | total_assets | 14,561,000,000 United States dollar | superseded | [clm_145EE73B11CB](/claim/clm_145EE73B11CB.md) - 2025-06-30 to 2025-09-30 | quarterly_revenue | 2,680,000,000 United States dollar | superseded | [clm_23E42E195A20](/claim/clm_23E42E195A20.md) - 2025-06-30 to 2025-09-30 | quarterly_operating_income | 291,000,000 United States dollar | superseded | [clm_483FA247004C](/claim/clm_483FA247004C.md) - 2025-06-30 to 2025-09-30 | total_equity | 12,124,000,000 United States dollar | superseded | [clm_8DFDC5A6BFEA](/claim/clm_8DFDC5A6BFEA.md) - 2025-06-30 to 2025-09-30 | quarterly_net_income | 906,000,000 United States dollar | superseded | [clm_9CD103447218](/claim/clm_9CD103447218.md) - 2025-06-30 to 2025-09-30 | cash_and_equivalents | 1,542,000,000 United States dollar | superseded | [clm_CBC6A719C2A4](/claim/clm_CBC6A719C2A4.md) - 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 394,000,000 United States dollar | superseded | [clm_D3F52CDFE778](/claim/clm_D3F52CDFE778.md) - 2025-09-30 to 2025-12-31 | total_equity | 12,511,000,000 United States dollar | superseded | [clm_3A067843B180](/claim/clm_3A067843B180.md) - 2025-09-30 to 2026-03-31 | quarterly_operating_income | 343,000,000 United States dollar | superseded | [clm_3A40EC910DDF](/claim/clm_3A40EC910DDF.md) - 2025-09-30 to 2026-03-31 | quarterly_revenue | 2,844,000,000 United States dollar | superseded | [clm_59161074BB2D](/claim/clm_59161074BB2D.md) - 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 375,000,000 United States dollar | superseded | [clm_B7AEE961CD25](/claim/clm_B7AEE961CD25.md) - 2025-09-30 to 2026-03-31 | quarterly_net_income | 264,000,000 United States dollar | superseded | [clm_E5141D715B4B](/claim/clm_E5141D715B4B.md) - 2025-09-30 to 2025-12-31 | cash_and_equivalents | 2,414,000,000 United States dollar | superseded | [clm_E78CE31BE3A3](/claim/clm_E78CE31BE3A3.md) - 2025-09-30 to 2025-12-31 | total_assets | 15,039,000,000 United States dollar | superseded | [clm_FEC704EE6F9B](/claim/clm_FEC704EE6F9B.md) - 2025-10-09 | coo | Jessica Hertz | valid | [clm_0162348917AE](/claim/clm_0162348917AE.md) - 2025-12-31 | net_income | 1,231,000,000 United States dollar | valid | [clm_0294D005D627](/claim/clm_0294D005D627.md) - 2025-12-31 to 2026-03-31 | total_assets | 15,189,000,000 United States dollar | superseded | [clm_092AEBD54B40](/claim/clm_092AEBD54B40.md) - 2025-12-31 | revenue | 11,556,000,000 United States dollar | valid | [clm_0D866B0EEDFB](/claim/clm_0D866B0EEDFB.md) - 2025-12-31 | research_and_development | 1,536,000,000 United States dollar | valid | [clm_2809D797CCBA](/claim/clm_2809D797CCBA.md) - 2025-12-31 | employees | 7,600 | valid | [clm_363A3065E010](/claim/clm_363A3065E010.md) - 2025-12-31 to 2026-03-31 | cash_and_equivalents | 1,545,000,000 United States dollar | superseded | [clm_43C364CB8FA3](/claim/clm_43C364CB8FA3.md) - 2025-12-31 to 2026-03-31 | total_equity | 13,473,000,000 United States dollar | superseded | [clm_9C88CFC9CFF9](/claim/clm_9C88CFC9CFF9.md) - 2025-12-31 | operating_income | 1,468,000,000 United States dollar | valid | [clm_FB75B3A0CC28](/claim/clm_FB75B3A0CC28.md) ## 2026 - 2026-03-31 to 2026-06-30 | cash_and_equivalents | 1,848,000,000 United States dollar | superseded | [clm_2FC256A9C5AC](/claim/clm_2FC256A9C5AC.md) - 2026-03-31 to 2026-06-30 | quarterly_net_income | -581,000,000 United States dollar | superseded | [clm_772C9108E80E](/claim/clm_772C9108E80E.md) - 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 437,000,000 United States dollar | superseded | [clm_84D91DB27406](/claim/clm_84D91DB27406.md) - 2026-03-31 to 2026-06-30 | total_equity | 12,501,000,000 United States dollar | superseded | [clm_90483F3FD78A](/claim/clm_90483F3FD78A.md) - 2026-03-31 to 2026-06-30 | total_assets | 14,121,000,000 United States dollar | superseded | [clm_D0FD6BFBFCEA](/claim/clm_D0FD6BFBFCEA.md) - 2026-03-31 to 2026-06-30 | quarterly_operating_income | 382,000,000 United States dollar | superseded | [clm_EBC3CE3FF775](/claim/clm_EBC3CE3FF775.md) - 2026-03-31 to 2026-06-30 | quarterly_revenue | 3,170,000,000 United States dollar | superseded | [clm_FB51C2B2C053](/claim/clm_FB51C2B2C053.md) - 2026-06-30 | total_equity | 12,684,000,000 United States dollar | valid | [clm_12A508B5D39A](/claim/clm_12A508B5D39A.md) - 2026-06-30 | cash_and_equivalents | 1,656,000,000 United States dollar | valid | [clm_264C663B1CB0](/claim/clm_264C663B1CB0.md) - 2026-06-30 | quarterly_revenue | 3,583,000,000 United States dollar | valid | [clm_351080AA769E](/claim/clm_351080AA769E.md) - 2026-06-30 | quarterly_net_income | 1,502,000,000 United States dollar | valid | [clm_6AB7F61BAEBB](/claim/clm_6AB7F61BAEBB.md) - 2026-06-30 | quarterly_operating_income | 488,000,000 United States dollar | valid | [clm_6FA40F52E535](/claim/clm_6FA40F52E535.md) - 2026-06-30 | total_assets | 14,470,000,000 United States dollar | valid | [clm_8D7D07681F83](/claim/clm_8D7D07681F83.md) - 2026-06-30 | quarterly_research_and_development | 445,000,000 United States dollar | valid | [clm_CE409FE8FECF](/claim/clm_CE409FE8FECF.md) - 2026-10-28 | market_cap | 214,120,000,000 United States dollar | unverified | [clm_5FC2E0C7CE99](/claim/clm_5FC2E0C7CE99.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.